Comparison of pentoxifylline and tacrolimus in the treatment of vitiligo patients
Phase 3
- Conditions
- vitiligo.Vitiligo
- Registration Number
- IRCT20120909010795N3
- Lead Sponsor
- Shiraz University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 35
Inclusion Criteria
Patients with vitiligo (with clinical diagnosis and Wood's Lamp)
Patients with at least two relatively and bilateral lesion.
Patients undergoing treatment with NBUVB
Residence in Shiraz, in case of non-residence in Shiraz, may attend meetings required for a visit.
Having the ability to understand Persian language written consent to participate in the study.
Exclusion Criteria
Over the last three months, they have received topical vitiligo medication
Unwillingness to receive local interventions
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Pigmentation. Timepoint: At the beginning of the study, one month and three months after starting treatment. Method of measurement: Qualitative measure with VASI score and quantitative measurement with dermocatch tool.
- Secondary Outcome Measures
Name Time Method